Home » Topics » BioWorld Science

BioWorld Science
RSS

Genzyme and NCI sign CRADA for melanoma gene therapy

Oct. 25, 1996

Aviron-NeuroVir gene therapy alliance

Oct. 25, 1996

Selective killing of p53-deficient human tumor cells with mutant adenovirus

Oct. 25, 1996

NIH seeks to license invention related to compounds inducing apoptosis

Oct. 25, 1996

Japanese researchers disclose anticancer applications of the E1AF gene

Oct. 25, 1996

NIH seeks licensees for novel laminin molecule that lacks affinity for collagen IV

Oct. 25, 1996

GV-1301 and GV-1302 available for licensing

Oct. 25, 1996

Follow-up confirms safety of PN-27.1

Oct. 25, 1996

New antitumor agent from Banyu

Oct. 25, 1996

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...